Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityAPLS / Apellis Pharmaceuticals, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership186,853 shares
Latest Disclosed Value $ 7,517,096
D. E. Shaw & Co., Inc. ownership in APLS / Apellis Pharmaceuticals, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 186,853 shares of Apellis Pharmaceuticals, Inc. (US:APLS) valued at $7,517,096 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 449,676 shares of Apellis Pharmaceuticals, Inc.. This represents a change in shares of -58.45% during the quarter. The current value of the position is $7,666,579 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (APLS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

APLS / Apellis Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 186,853 -262,823 -58.45 7,517 -33.45 0.0045
2026-02-17 2025-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 449,676 -7,115 -1.56 11,296 9.27 0.0062
2025-11-14 2025-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 456,791 205,722 81.94 10,337 137.85 0.0058
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 251,069 251,069 4,346 0.0031
2025-05-15 2025-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -20,000 -100.00 0 -100.00
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 20,000 20,000 638 0.0005
2024-05-15 2024-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -33,086 -100.00 0 -100.00
2024-02-14 2023-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 33,086 -6,387 -16.18 1,981 31.91 0.0017
2023-11-14 2023-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 39,473 -488,338 -92.52 1,502 -96.88 0.0016
2023-08-14 2023-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 527,811 114,958 27.84 48,084 76.57 0.0491
2023-05-15 2023-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 412,853 399,955 3,100.91 27,232 3,988.74 0.0292
2023-02-14 2022-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 12,898 -184,466 -93.46 667 -95.06 0.0007
2022-11-14 2022-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 197,364 192,794 4,218.69 13,480 6,412.08 0.0161
2022-08-15 2022-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 4,570 -28,464 -86.17 207 -87.66 0.0002
2022-05-16 2022-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 33,034 -4,856 -12.82 1,678 -6.31 0.0016
2022-02-14 2021-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 37,890 -37,632 -49.83 1,791 -28.04 0.0015
2021-11-15 2021-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 75,522 -169,507 -69.18 2,489 -83.93 0.0022
2021-08-16 2021-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 245,029 -91,614 -27.21 15,486 7.21 0.0134
2021-05-17 2021-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 336,643 -77,419 -18.70 14,445 -39.01 0.0139
2021-02-16 2020-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 414,062 28,196 7.31 23,684 103.44 0.0212
2020-11-16 2020-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 385,866 -145,895 -27.44 11,642 -32.96 0.0119
2020-08-14 2020-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 531,761 162,028 43.82 17,367 75.34 0.0207
2020-05-15 2020-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 369,733 221,326 149.13 9,905 117.98 0.0155
2020-02-14 2019-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 148,407 137,342 1,241.23 4,544 1,601.87 0.0052
2019-11-14 2019-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 11,065 11,065 267 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F APELLIS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F APELLIS PHARMACEUTICALS COM Call 13,900 0.00 349 11.15 n/a n/a n/a
2025-11-14 2025-09-30 13F APELLIS PHARMACEUTICALS COM Call 13,900 0.00 315 30.83 n/a n/a n/a
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM Call 13,900 -23.63 241 -39.70 n/a n/a n/a
2025-05-15 2025-03-31 13F APELLIS PHARMACEUTICALS COM Call 18,200 -42.59 398 -60.63 n/a n/a n/a
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM Call 31,700 0.00 1,012 10.61 n/a n/a n/a
2024-11-14 2024-09-30 13F APELLIS PHARMACEUTICALS COM Call 31,700 -9.17 914 -31.69 n/a n/a n/a
2024-08-14 2024-06-30 13F APELLIS PHARMACEUTICALS COM Call 34,900 -7.43 1,339 -39.62 n/a n/a n/a
2024-05-15 2024-03-31 13F APELLIS PHARMACEUTICALS COM Call 37,700 27.80 2,216 25.55 n/a n/a n/a
2024-02-14 2023-12-31 13F APELLIS PHARMACEUTICALS COM Call 29,500 0.00 1,766 57.31 n/a n/a n/a
2023-11-14 2023-09-30 13F APELLIS PHARMACEUTICALS COM Call 29,500 0.00 1,122 -58.24 n/a n/a n/a
2023-08-14 2023-06-30 13F APELLIS PHARMACEUTICALS COM Call 29,500 2,687 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F APELLIS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F APELLIS PHARMACEUTICALS COM Put 15,000 0.00 377 10.91 n/a n/a n/a
2025-11-14 2025-09-30 13F APELLIS PHARMACEUTICALS COM Put 15,000 -33.92 339 -13.52 n/a n/a n/a
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM Put 22,700 -40.42 393 -52.94 n/a n/a n/a
2025-05-15 2025-03-31 13F APELLIS PHARMACEUTICALS COM Put 38,100 22.90 833 -15.77 n/a n/a n/a
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM Put 31,000 989 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.